Close
ACHEMA MIDDLE EAST 2026

How Liposomal Nanotechnology Helps Improve Bioavailability in Nutraceuticals

In the last few years, there has been a rapid increase in the uptake of nutritional supplements for improving health and well-being. In the...

Ancient Viral DNA Guards Against Infections In Human Genome

According to new research, ancient infections that left viral DNA in human genomes act as antivirals to shield human cells from some modern viruses. A...

EMA Wants To Limit Immune-Regulating Medications Like FDA

On October 28th, an advisory board to the European Medicines Agency advised restricting the use of a class of medications for inflammatory diseases due...

China Brings To The Table First COVID Inhaler Vaccination

A new type of COVID-19 vaccination that is provided via inhalation rather than injection was this week introduced in Shanghai, the commercial city of...

Omicron Subvariants Withstand Essential Antibody Treatments

The White House issued a warning this week that HIV patients, kidney transplant recipients, and other immunocompromised people are particularly susceptible to COVID this...

CPHI Report Says, Biologics Outsourcing Will Surge In 2023

Part I of the CPHI Annual Report looks ahead at the potential for biologics outsourcing and contract manufacturing organisations (CMOs) in 2023 in advance...

Research And Development In UK Falls Behind Other Nations

According to a new report by IPPR, the UK's percentage of worldwide research and development (R&D) spending has decreased by 5% since 2014. Even...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...